Stay updated on GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial
Sign up to get notified when there's something new on the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page.
Latest updates to the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedDifference1%
- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the page header, with no changes to study details, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check50 days agoChange DetectedRemoved the government funding operating-status notice from the page.SummaryDifference0.3%
- Check64 days agoChange DetectedNo additions or deletions to core study content observed; the title, conditions, eligibility criteria, enrollment, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check93 days agoChange DetectedUpgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.SummaryDifference3%
- Check100 days agoChange DetectedRenaming a medical condition to a more precise term and updating versioning from v3.0.2 to v3.1.0; older terms and unrelated melanoma entry removed.SummaryDifference0.8%
Stay in the know with updates to GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page.